p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
about
Extracellular Vesicles as New Players in Cellular SenescenceChemoprevention of Breast Cancer by Dietary PolyphenolsWip1 phosphatase: between p53 and MAPK kinases pathwaysmTOR-dependent cell survival mechanismsTransformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation processE2F1 regulates cellular growth by mTORC1 signaling.Alternative fuel--another role for p53 in the regulation of metabolism.p53 Research: the past thirty years and the next thirty years.Different patterns of Akt and ERK feedback activation in response to rapamycin, active-site mTOR inhibitors and metformin in pancreatic cancer cells.Association of the insulin-like growth factor binding protein 3 (IGFBP-3) polymorphism with longevity in Chinese nonagenarians and centenarians.Identification of potential synthetic lethal genes to p53 using a computational biology approachSuppression of AMPK activation via S485 phosphorylation by IGF-I during hyperglycemia is mediated by AKT activation in vascular smooth muscle cellsKnockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicinNutrient starvation affects expression of LC3 family at the feto-maternal interface during murine placentationTumor-suppressive sphingosine-1-phosphate receptor-2 counteracting tumor-promoting sphingosine-1-phosphate receptor-1 and sphingosine kinase 1 - Jekyll Hidden behind HydeMesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.Hypoglycemia, hyperglucagonemia, and fetoplacental defects in glucagon receptor knockout mice: a role for glucagon action in pregnancy maintenance.Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases.Adaptive response, evidence of cross-resistance and its potential clinical useMetformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways.Correlation Between RAB27B and p53 Expression and Overall Survival in Pancreatic Cancer.CHMP4C Disruption Sensitizes the Human Lung Cancer Cells to Irradiation.The regulation of cellular metabolism by tumor suppressor p53.Metformin use and improved response to therapy in rectal cancer.Conserved versatile master regulators in signalling pathways in response to stress in plants.Ursolic Acid-Regulated Energy Metabolism-Reliever or Propeller of Ultraviolet-Induced Oxidative Stress and DNA Damage?Torin1-mediated TOR kinase inhibition reduces Wee1 levels and advances mitotic commitment in fission yeast and HeLa cellsTargeting mTOR network in colorectal cancer therapyAKT mediates actinomycin D-induced p53 expression.Negative regulation of autophagyAutophagy, reactive oxygen species and the fate of mammalian cells.The potential effects of IGF-1 and GH on patients with chronic heart failure.Cell cycle regulatory molecular profiles of pediatric T-cell lymphoblastic leukemia and lymphoma.Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects.The STEAP protein family: versatile oxidoreductases and targets for cancer immunotherapy with overlapping and distinct cellular functions.The senescence hypothesis of disease progression in Alzheimer disease: an integrated matrix of disease pathways for FAD and SAD.Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding.Role of the Crosstalk between Autophagy and Apoptosis in CancerAutophagy, a novel target for chemotherapeutic intervention of thyroid cancer.PI3K/Akt-mediated regulation of p53 in cancer.
P2860
Q26738427-E92A5019-9EEF-477B-A1EF-5783A7547271Q26773449-C67DEF26-7F38-4426-961A-5C620172C476Q26863035-08B6E6AC-5CC2-4892-87FD-68AFD1A2D38DQ26864688-92DB8F8A-1294-4A9B-9048-7C58ECAEE3B0Q30405908-0D1B425C-5E42-4504-B8BF-96DF1AFCA286Q33808832-DE1AE440-3B3D-4993-BD66-ADC29B84BE62Q33841854-06EBBE9D-C4C5-4CC5-A283-BC98E3C99E03Q34313764-C76A35F2-F2B8-4A69-951F-F3DF25EF2DF2Q34600369-507BC8B2-87AE-4AE0-9E4F-0AAA5CA7340EQ34774279-188083F5-39C7-41A6-834B-8D141CCD9F5EQ34985284-3DFD2470-C51D-435B-B998-041AD29B1296Q35110805-BB05B4F9-4612-4769-A167-40C5A2C2600BQ35159686-7E4C0B45-1654-4907-B26F-E3BCE53934D3Q35252465-4231FE01-B428-43EF-8106-45298B750B00Q35264010-37FEA46C-7E7F-4BBF-9DD0-C2C80AB841B6Q35594874-8157A96F-76F0-433B-8ACE-34A59354535EQ35849360-2BDB78B3-AFFF-4B6D-9771-FB2107E6532EQ36081720-5EEF1255-4E1E-4D80-A271-4B821FF2ADA8Q36321702-2F9E1548-0173-43D7-98A3-CF7E5CB68C5AQ36361245-796D5345-6ECE-40A3-83E3-F433C59CC633Q36467279-4EA75739-6770-4E52-9854-0647345133CFQ36512388-FC8A4C65-3C1B-4550-9F7D-B27A544AA935Q36614219-75627C55-C7F7-48CF-92E2-8809E5B978E8Q37231995-A477DC05-34DA-48BB-903E-6543AFDB8B61Q37240377-DBF41015-9F83-4E06-87A3-042C02E860A8Q37636467-0BB81546-C616-4309-8542-B228CC2B15A5Q37636596-6E1B6FDD-E69A-464D-B3C9-6025759621DEQ37708005-ECEBD023-AE3F-4075-B3BC-F97DF1B1AC3CQ37718441-C8BB14D1-893F-4A6D-B8F6-3B350F40362AQ37791832-CA038892-16BA-4113-9120-6374F23DC21DQ37801925-2EE94077-D3D4-429D-B6AF-C3017BC1B2B1Q37860065-00910C70-5A38-48D4-8387-CF55B5BDBEB5Q37920890-6C8BC64B-846F-4879-A144-823D0AB9C2DFQ38016107-2E9041C3-0905-4729-BFDE-D94FB849FE19Q38026940-CB74C53A-54E2-4B3C-B43E-09A997881FC4Q38094984-FB3A0DE4-1D9F-4288-98A8-C69475AF7E93Q38102636-6A7FB799-8336-40AE-9912-C1F5857B5331Q38120523-611B5000-3B0D-4BF2-BEBD-3B653B7C5EE2Q38168724-5E811BC6-783E-4F07-ADC8-D9B4C34BB50BQ38238609-674586E2-0B0E-409B-A827-30D6004270DD
P2860
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@en
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@nl
type
label
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@en
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@nl
prefLabel
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@en
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@nl
P2860
P1476
p53 regulation of the IGF-1/AKT/mTOR pathways and the endosomal compartment.
@en
P2093
Zhaohui Feng
P2860
P304
P356
10.1101/CSHPERSPECT.A001057
P577
2010-02-01T00:00:00Z